Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1280 in its research report dated January 26, 2023.

ICICI Direct is bullish on Cipla recommended buy rating on the stock with a target price of Rs 1290 in its research report dated January 27, 2023.

"Pharma is certainly one of the spaces that one should look at because that is one of the space which has not done anything at all. They have only gone down. I think one should definitely look into some of the frontline pharma stocks like Sun Pharma, Lupin, Cipla. I will also be a little more comfortable with something like Larsen & Toubro or Siemens or ABB."

Sharekhan recommended Hold rating on Cipla with a target price of Rs 1158 in its research report dated January 25, 2023.

The NSE Nifty index was trading 206.9 points down at 17685.05

Adani Ports SEZ, Adani Ent., ICICI Bank, HDFC and ONGC were among the top losers on NSE.

“The critical point for Tata Motors always was that the operating leverage is so huge that once the turnaround happens and if it sustains, then the profits which come will be so large that the stock becomes suddenly very cheap. Most analysts have projections of Rs 30 to 50 EPS for next year and the stock is cheap. We have bought into Tata Motors after a long time. There could be significant upsides over the next two years.”

EBITDA margin improved by 176 bps YoY to 24.2% despite soft Revlimid sales, mainly driven by an improvement in the mix. The net profit grew by 9.9% YoY to Rs8bn mainly on the back of a strong operational performance, which was partially offset by a higher tax rate on account of DTA reversal.

The NSE Nifty index was trading 183.8 points down at 17708.15

Touchwood Entertainm, Jindal Saw, Advitiya Trade India, Bombay Super Hybrid and Upsurge Seeds of Agriculture Ltd., hit their fresh 52-week highs at 10:04AM.

Macquarie has kept ‘Outperform’ rating on Cipla with a target at Rs 1,235 per share

On January 25, Indian rupee closed 13 paise higher at 81.59 per dollar against Tuesday's close of 81.72.

The NSE Nifty index closed 226.35 points down at 17891.95

The NSE Nifty index closed 226.35 points down at 17891.95

With earnings of index heavyweight Reliance out of the way, some major companies, including Axis Bank, Maruti Suzuki, Tata Motors, Bajaj Auto, Cipla, Bajaj Finance, Vedanta, and NTPC, among others, are slated to announce their third-quarter results this week. The markets on Monday will also react to RIL's earnings, which disappointed the Street, as well as other index majors ICICI Bank and Kotak Bank.

Net Sales are expected to increase by 16 percent Y-o-Y (up 8.3 percent Q-o-Q) to Rs 63,138 crore, according to Nirmal Bang.

Sula Vineyards Ltd., Generic Engg, Innovana Thinklabs, Network People Services Technologies Ltd. and Upsurge Seeds of Agriculture Ltd., hit their fresh 52-week highs at 11:27AM.

However, in FY24 what we believe is that the government will again allow pharma companies to take price increases anywhere in the range of 12% to 13% on the NLEM drugs and the non-NLEM drugs again about up to 10% which will help the price realisation in terms of growth.

The NSE Nifty index closed 37.5 points down at 17858.2

Divis Labs, RIL, BPCL, Axis Bank and Tata Motors were among the top losers on NSE in today's trade.

Kandarp Digi Smart BPO Ltd., Generic Engg, Cool Caps Industries Ltd., Rico Auto and Sat Industries, hit their fresh 52-week highs during the day.

Generic Engg, Indiabulls Enterprises Ltd., Sky Gold, Trans & Rectif and 3P Land Holdings, hit their fresh 52-week highs during the day.

Bharti Airtel, Cipla, Divis Labs, Apollo Hospital and HUL were among the top losers on NSE in today's trade.

The NSE Nifty index closed 18.45 points down at 17895.7

The NSE Nifty index closed 18.45 points down at 17895.7

The NSE Nifty index was trading 25.65 points up at 17939.8

Generic Engg, Indiabulls Enterprises Ltd., Ponni Sugars, Sky Gold and 3P Land Holdings, hit their fresh 52-week highs at 10:35AM.

Bharti Airtel, Cipla, Apollo Hospital, Divis Labs and ONGC were among the top losers on NSE.

The NSE Nifty index closed 50.8 points down at 17992.15

“Coming to the complex generics opportunity, Cipla and Lupin are most exposed. We like Cipla more than Lupin because at least in the near term, there are multiple assets waiting to play out. For Cipla this year, we are hoping to see generic Advair, generic Abraxane which is most likely in the price but beyond that, there will be a generic Qvar, there will be a generic Teriparatide and potentially a generic Flovent as well.”

The NSE Nifty index was trading 103.55 points down at 18129.0

Avro India, Mold Tek Tech, Baheti Recycling Industries Ltd., Varanium Cloud Ltd. and Wonder Fibromats, hit their fresh 52-week highs at 09:59AM.

Avro India, Pritika Engineering Components Ltd., Tainwala Chem, Baheti Recycling Industries Ltd. and Gujarat Pipavav, hit their fresh 52-week highs at 10:56AM.

The investment will facilitate a long-term strategic partnership between Cipla and Ethris for development of messenger RNA (mRNA)-based therapies, the former said in a release

Cipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 86522.68 Crore) operating in Pharmaceuticals sector.

The city-headquartered company started its investment journey on the automation front two years ago and has already been recognised for its work by multiple bodies, Geena Malhotra, the chief technology officer for the company, told PTI recently.

SecUR Credentials, Usha Martin, Network People Services Technologies Ltd., Ascom Leasing & Inve and Gretex Industries, hit their fresh 52-week highs during the day.

The NSE Nifty index closed 207.8 points up at 18014.6

The NSE Nifty index closed 207.8 points up at 18014.6

Cipla key Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2022.